Review Article

Is Gastroparesis Found More Frequently in Patients with Cystic Fibrosis? A Systematic Review

Table 1

Studies evaluating gastric emptying in cystic fibrosis.

AuthorYearLocationSubjectsGender Age DMPancreatic insufficiencyInterventionResult
MaleMean
CFControlsTotalCFControlsCFControlsCFControlsCFControls

⁢Capsule methods
Hedsund et al. [14]2012Denmark10162659232600100NoNo difference
Gelfond et al. [15]2013Buffalo, NY1010203321.722.500100NoNo difference

⁢C-Octanoic breath test
De Boeck et al. [5]1998Belgium1111410.511Creon and high-lipase Creon in CF.No control group
Symonds et al. [9]2003Australia1012225710.212.5NA0100Pancreas in CFNo difference
Neumann et al. [16]2003Czech Republic2020NA13.5NoNo difference
Hauser et al. [17]2010Belgium1919135NoNo control group
Pauwels et al. [18]2011Belgium33331828031NoNo control group
Hauser et al. [19]2013Belgium22221290NoNo control group

⁢Scintigraphy with technetium
Davidson et al. [20]1995Canada7070NANANoNo control group
Carney et al. [21]1995Australia511163425210050NoCF Faster
Collins et al. [22]1997Australia1917368812.612.820190Usual dose of PERT in CFCF Faster
Munck et al. [23]1997France77NANAErythromycin in CFNo control group
Couturier et al. [24]2004France4853101NA42NA31.84NA0NA0NoCF Slower
King et al. [25]2006Australia22228NA18Usual dose of PERT in CFNo control group
Tonelli et al. [26]2009Gainesville, FL55125.225IV Erythromycin in CFNo control group
Luu et al. [27]2011Canada1717NANAMeasurements before and after Cisapride in CFNo control group
Kuo et al. [28]2011Australia56113325.821.70056Creon versus Placebo in CFCF Faster
Mendez et al. [29]2012Chicago, Il1078888382859NANANANANoCF Slower
Rovner et al. [4]2013Philadelphia, PA1612289616.728.600160Creon in CFNo difference
359215574100 (50.76%)120 (55.81%)4 (5.71%)0 (0.00%)140 (84.85%)6 (4.38%)

Of available data.
CF: cystic fibrosis and NA: data not available.